Newland Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Newland Pharmaceutical has a total shareholder equity of CN¥1.5B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.7B and CN¥220.0M respectively. Newland Pharmaceutical's EBIT is CN¥169.4M making its interest coverage ratio -9. It has cash and short-term investments of CN¥860.6M.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | -9x |
Cash | CN¥860.60m |
Equity | CN¥1.51b |
Total liabilities | CN¥219.95m |
Total assets | CN¥1.73b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 301277's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥175.2M).
Long Term Liabilities: 301277's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥44.7M).
Debt to Equity History and Analysis
Debt Level: 301277 is debt free.
Reducing Debt: 301277 has no debt compared to 5 years ago when its debt to equity ratio was 28%.
Debt Coverage: 301277 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 301277 has no debt, therefore coverage of interest payments is not a concern.